An assay for the binding of ['Hlthyrotropin-releasing The secretion of thyrotropin by the anterior pituitary gland is controlled by a neurohormone synthesized in the hypothalamic area and carried to its adenohypophyseal site of action by a portal system (1-3). A major contribution in the field of neuroendocrinology has been the recent elucidation of the structure of this neurohormone (thyrotropin-releasing horrnone, TRH) as L-pyroglutamyl-ihistidyl-rproline amide (4, 5). The availability of the first synthetic hypothalamic releasing hormone in a pure form opens new possibilities for the study of the mechanism of action of this peptide in the anterior pituitary gland.
The secretion of thyrotropin by the anterior pituitary gland is controlled by a neurohormone synthesized in the hypothalamic area and carried to its adenohypophyseal site of action by a portal system (1) (2) (3) . A major contribution in the field of neuroendocrinology has been the recent elucidation of the structure of this neurohormone (thyrotropin-releasing horrnone, TRH) as L-pyroglutamyl-ihistidyl-rproline amide (4, 5) . The availability of the first synthetic hypothalamic releasing hormone in a pure form opens new possibilities for the study of the mechanism of action of this peptide in the anterior pituitary gland.
There is strong evidence of a role for adenylate cyclase as a mediator of the action of the hypothalamic releasing hormones (6) (7) (8) (9) (10) (11) . We have found (unpublished data) that adenylate cyclase, the enzyme catalyzing the formation of cyclic AMP, is associated with the plasma membranes in anterior pituitary tissue. The possibility of a specific binding of [3HJTRH to the adenohypophyseal plasma membranes as their primary action was somewhat strengthened by studies with radio-iodinated adrenocorticotropin (12, 13) , insulin (14) (15) (16) (17) (18) , angiotensin (19) , and glucagon (20) (21) (22) , that 
for 40 min. The reaction is stopped by the addition of 1.0 ml of ice-cold buffer F, and the medium is immediately filtered with gentle suction through a Millipore filter, with three successive washes of the adsorbed material with 2 ml of the ice-cold buffer. After the filter is dried at 600C for 30 min, 10 increase in TRH binding between 2.5 and 5.0 mM K+, a plateau being observed between 5 and 25 mM, with a subsequent decrease reaching values below the control at 100 mM K+ (data not shown). When NaCl is added to the standard incubation medium, there is no effect of Na++ ions up to a concentration of 120 mM. Maximal stimulation by Mg++ is observed at concentrations of 0.5-2.5 mM, with subsequent inhibition of binding at higher concentrations (Fig. 4) . When the binding assay is performed in the presence of 1 mM Mg++, Mn++ gives a pattern similar to that of Mg++, while Ca++ is inhibitory at all concentrations (Fig. 4) (Table 1) . Similarly, no competition is observed when various peptide hormones (porcine adrenocorticotropin, bovine luteinizing hormone, bovine growth hormone, bovine prolactin, bovine insulin, and porcine glucagon) are added at 10 JAM, well above the physiological plasma concentration (Table 1) . Coupled with the dilution experiment with unlabeled TRH, these data indicate that the site of binding of TREI is highly specific, and validate the use of the described assay for investigation of the specific binding of TRH.
In view of the well-known inhibitory feedback effect of thyroid hormone on TRH action in the anterior pituitary gland (29, 30) , it is interesting to note that thyroxine or triiodothyronine have no influence on the binding of TRH to plasma membranes (Table 1) , thus providing evidence for an action of thyroid hormone at a site subsequent to the binding of TRH to its receptor.
DISCUSSION
Despite its central importance in the direct control of thyrotropin secretion, and its indirect effect on the secretion of the many hormones influenced by the concentration of circulating thyroid hormone (31, 32) , little is understood about the mechanism of action of TRH in molecular terms. The availability of synthetic TRH labeled at high specific activity in its proline residue makes it possible to study the interaction of this very important molecule with its receptors in the anterior pituitary gland. Such a study avoids limitations inherent in the use of radiolabeled derivatives of peptide hormones.
A high degree of specificity of the TRH receptor is suggested by the absence of competition for TRH binding by two peptide hormones of hypothalamic origin, and by six other peptide hormones. The interaction of TRH and its receptor follows standard bimolecular reaction kinetics, and the reaction is reversible. Unlabeled TRH displaces the labeled hormone in proportion to its relative concentration; virtually complete inhibition of [3H]TRH binding was observed in the presence of 10 gM unlabeled TRH. However, when [3HJTRH and receptor have reached equilibrium, excess unlabeled TRH usually fails to displace 20-40% of the bound radioactivity after 1 hr of incubation. The remaining bound radioactivity is somewhat higher than the value expected from the rate of dissociation measured in the first 20 min. Under comparable conditions, only 10-20% of glucagon was displaced from liver membranes at 00C in the presence of 1 mM EDTA, and negligible dissociation could be measured in the absence of the chelating agent (21) . About 10% of bound '25I-labeled insulin was not displaced by excess unlabeled hormone (16) . There is no satisfactory explanation for these results.
The concentration of TRH giving half-maximal binding to the receptor (23 nM) is in the range of concentrations found efficient in eliciting the best-known effect of this neurohormone, TSH release by the anterior pituitary gland incubated in vitro (33) . It is most likely that the concentration of TRH in the portal blood supplying the TSH-secreting cells of the anterior pituitary gland is in this range of concentrations.
Since calcium is required for the TRH-induced release of thyrotropin (34) , it is noteworthy that addition of calcium depresses binding of the labeled hormone at all concentrations studied. It should be mentioned that physiological concentrations of Ca++ only inhibit [8H]TRH binding about 5%.
These findings eliminate the TRH-receptor interaction as a possible site for the permissive action of Ca++ on thyrotropin release. Likewise, the binding of ACTH to the adrenal receptor does not require Ca++ (13) There are very interesting recent data on the interaction of ACTH (12, 13) , insulin (14) (15) (16) (17) (18) , and glucagon (20) (21) (22) with receptors in their target cells. Among the striking similarities of the characteristics of binding of these relatively large peptides with those of the tripeptide TRH, there are the high equilibrium constant and specificity and, possibly more important, the location of the receptor in the plasma membrane, which is also the main site of the adenylate cyclase in mammalian tissues (35) (36) , including the anterior pituitary gland. *Incubations were performed as described under "Methods", except for the presence of indicated hormones. The molecular weights of growth hormone and prolactin were taker, respectively, as 20,846 and 23,500 (27, 28) .
